Showing results (1161-1170 of 1,199) with videos related to
Sort By:
Pageof 120
Frontiers in Molecular Biosciences|February 15, 2021
Baicalin Induces Apoptosis and Suppresses the Cell Cycle Progression of Lung Cancer Cells Through Downregulating Akt/mTOR Signaling PathwayXinbing Sui, Xuemeng Han, Peng Chen, et al.Nature Communications|September 9, 2022
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignanciesYongxian Hu, Jingjing Li, Fang Ni, et al.The Journal of Clinical Investigation|May 14, 2024
The long noncoding RNA CARDINAL attenuates cardiac hypertrophy by modulating protein translationXin He, Tiqun Yang, Yao Wei Lu, et al.JACC. Basic to Translational Science|March 4, 2026
Global Burden of Rheumatic Heart Disease (1990-2021), Attributable Risk Factors, and Future ProjectionsYuping Zou, Siyu Wei, Qinduo Ren, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 12, 2021
Ten Years of EWASSiyu Wei, Junxian Tao, Jing Xu, et al.Journal of Neural Engineering|September 25, 2024
Epidural spinal cord recordings (ESRs): sources of neural-appearing artifact in stimulation evoked compound action potentialsAshlesha Deshmukh, Megan Settell, Kevin Cheng, et al.Kidney International|January 20, 2023
Downregulation of G protein-coupled receptor kinase 4 protects against kidney ischemia-reperfusion injuryDonghai Yang, Ming Tang, Mingming Zhang, et al.Nature|August 31, 2022
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHLJiqin Zhang, Yongxian Hu, Jiaxuan Yang, et al.Nature Medicine|September 24, 2025
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trialJingjing Feng, Dawei Huo, Ruimin Hong, et al.Journal for Immunotherapy of Cancer|March 28, 2025
Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myelomaChunxiang Jin, Rongrong Chen, Shan Fu, et al.Pageof 120